Singapore vs Switzerland: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Singapore
91.0%
in 2024
Switzerland
91.0%
in 2024
Singapore rank
52nd
Switzerland rank
52nd
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Singapore
- Switzerland
How they compare
Singapore currently reports 91.0% against 91.0% in Switzerland, a difference of 0.0%.
The two have swapped places 4 times across 16 shared years of data; in 2009 it was Switzerland ahead.
Singapore ranks 52nd and Switzerland ranks 52nd of 146 countries.
Across the 3 decades both report, Singapore averaged higher in 1 and Switzerland in 2.
Head to head by decade
| Decade | Singapore | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.0% | 25.0% | 8.0% | Switzerland |
| 2010s | 64.6% | 71.6% | 7.0% | Switzerland |
| 2020s | 89.8% | 88.6% | 1.2% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Singapore or Switzerland?
- Singapore, at 91.0% against 91.0% in Switzerland as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Singapore and Switzerland?
- 0.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Switzerland?
- 16 years are reported by both, from 2009 to 2024.
- How do Singapore and Switzerland rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Singapore ranks 52nd and Switzerland ranks 52nd of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.